跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“Vβ10”
全部
40
临床试验
25
药物
6
机构
0
资讯
9
去年
Marengo's Invikafusp Alfa Shows Promise in Anti-PD-1 Resistant Solid Tumors
2个月前
Marengo Secures ESMO 2026 Oral Presentation for Phase 2 Invikafusp Alfa Data in PD-1–Resistant Solid Tumors, Appoints KEYTRUDA Development Leader Eric Rubin to Scientific Advisory Board
去年
Invikafusp Alfa Shows Promise in PD-1 Resistant Solid Tumors
去年
Marengo Therapeutics Strengthens Leadership with Pfizer Veteran Dolsten and Oncology Expert Tabernero
去年
Invikafusp Alfa Demonstrates Promising Activity in Immune Checkpoint Inhibitor-Resistant Solid Tumors
去年
Marengo's Invikafusp Alfa Shows Promise in Anti-PD-1 Resistant Cancers
11个月前
Invikafusp Alfa Shows Promise in Checkpoint Inhibitor-Resistant Solid Tumors with High Disease Control Rates
去年
FDA Grants Fast Track Designation to Invikafusp Alfa for Advanced Colorectal Cancer
5个月前
Marengo Therapeutics Reports Confirmed Complete Responses in Phase 2 Trial of Invikafusp Alfa Plus TRODELVY for Metastatic Breast Cancer